EP0095502A4 - Anticorps humains monocloniques ou lymphocines dans la separation de cellules ou dans le diagnostic du cancer du sein. - Google Patents

Anticorps humains monocloniques ou lymphocines dans la separation de cellules ou dans le diagnostic du cancer du sein.

Info

Publication number
EP0095502A4
EP0095502A4 EP19830900257 EP83900257A EP0095502A4 EP 0095502 A4 EP0095502 A4 EP 0095502A4 EP 19830900257 EP19830900257 EP 19830900257 EP 83900257 A EP83900257 A EP 83900257A EP 0095502 A4 EP0095502 A4 EP 0095502A4
Authority
EP
European Patent Office
Prior art keywords
lymphokines
diagnosis
cells
separation
monoclonal antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19830900257
Other languages
German (de)
English (en)
Other versions
EP0095502A1 (fr
Inventor
Anthony J Strelkauskas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of South Carolina
Medical University of South Carolina MUSC
Original Assignee
University of South Carolina
Medical University of South Carolina MUSC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of South Carolina, Medical University of South Carolina MUSC filed Critical University of South Carolina
Publication of EP0095502A1 publication Critical patent/EP0095502A1/fr
Publication of EP0095502A4 publication Critical patent/EP0095502A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015Breast
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • C12N5/163Animal cells one of the fusion partners being a B or a T lymphocyte

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP19830900257 1981-12-08 1982-12-08 Anticorps humains monocloniques ou lymphocines dans la separation de cellules ou dans le diagnostic du cancer du sein. Withdrawn EP0095502A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32873881A 1981-12-08 1981-12-08
US39883982A 1982-07-16 1982-07-16
US328738 1999-06-09
US398839 1999-09-17

Publications (2)

Publication Number Publication Date
EP0095502A1 EP0095502A1 (fr) 1983-12-07
EP0095502A4 true EP0095502A4 (fr) 1987-01-20

Family

ID=26986489

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19830900257 Withdrawn EP0095502A4 (fr) 1981-12-08 1982-12-08 Anticorps humains monocloniques ou lymphocines dans la separation de cellules ou dans le diagnostic du cancer du sein.

Country Status (5)

Country Link
EP (1) EP0095502A4 (fr)
JP (1) JPS58502132A (fr)
CA (1) CA1200484A (fr)
DK (1) DK325183A (fr)
WO (1) WO1983002058A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707438A (en) * 1984-08-22 1987-11-17 Tel Aviv University Immunoassay for breast cancer employing monoclonal antibodies
DK172110B1 (da) * 1988-04-15 1997-10-27 Gen Hospital Corp Fremgangsmåde til isolation af mutanter af DNA-sekvenser og anvendelsen heraf til identifikation af celleoverfladeproteiner

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
WO1982001461A1 (fr) * 1980-07-18 1982-05-13 Leland Stanford Junior Univ Hybridomes humains, precurseurs et produits
WO1982001192A1 (fr) * 1980-09-25 1982-04-15 Inst Biolg Studies Salk Anticorps monocloniques specifiques des glycoproteines de surface des cellules hemopoietiques humaines
NZ198851A (en) * 1980-11-07 1984-07-31 Wistar Inst Stable,continuous human myeloma cell line capable of hybridisation with antibody-producing cells:production of hybrid cell line

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8302058A1 *

Also Published As

Publication number Publication date
DK325183D0 (da) 1983-07-14
CA1200484A (fr) 1986-02-11
WO1983002058A1 (fr) 1983-06-23
EP0095502A1 (fr) 1983-12-07
JPS58502132A (ja) 1983-12-15
DK325183A (da) 1983-07-14

Similar Documents

Publication Publication Date Title
EP0161941A3 (en) Monoclonal antibody useful in the diagnosis of human stomach or breast cancer
GB2102810B (en) Human interferon-related peptides antigens antibodies and process for preparing the same
IL67721A (en) Hybridoma cell lines,their preparation and their use for the production of human monoclonal antibodies
IL76142A0 (en) Monoclonal antibody specific to human carcinoma tumorassociated antigen,hybrid cell lines producing the same and methods for the use thereof
AU529210B3 (en) Monoclonal antibody in occult blood diagnosis
GB2169921B (en) Antibodies having dual specificities, their preparation and uses therefor
EP0119556A3 (en) Monoclonal antibodies to human colon cancers and method
GB2109407B (en) Tumour imaging with radiolabelled monoclonal antibodies
IL63354A (en) Human hybridomas,their production and antibodies derived therefrom
ZA859761B (en) Monoclonal antibodies and antigen for human non-small cell lung carcinomas
GR870294B (en) Monoclonal antibodies and antigen for human non - small cell lung carcinoma and certain other human carcinomas
ZA858371B (en) Monoclonal antibodies for human non-small cell lung carcinomas
NO830570L (no) Antistoffer og antigener for diagnose og behandling av cancer
IL70968A0 (en) Urea-linked immunogens,their preparation and antibodies thereto
EP0160446A3 (en) Breast tumor-associated antigen and monoclonal antibodies specific thereto
EP0131627A4 (fr) Antigenes specifiques de la famille cea (antigene carcino-embryonaire), anticorps specifiques de ces antigenes et leurs procedes d'utilisation.
IL61641A0 (en) Immunological detection of human cancer cells and antigens and antibodies for use therein
EP0119528A3 (en) Monoclonal antibodies to human renal cancer antigens and method
EP0095502A4 (fr) Anticorps humains monocloniques ou lymphocines dans la separation de cellules ou dans le diagnostic du cancer du sein.
GB2079938B (en) Ultrasonic examination using section images
IL83342A0 (en) Monoclonal antibodies,their preparation and their use
PT81454B (en) Monoclonal antibodies specific for human squamous lung carcinoma cells their preparation and use
EP0060871A4 (fr) Anticorps monocloniques specifiques des glycoproteines de surface des cellules hemopoietiques humaines.
GB2097425B (en) Monoclonal antibody for b type blood cells
EP0207170A4 (fr) Procede de preparation d'un anticorps monoclonal specifique du cancer humain.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19830727

AK Designated contracting states

Designated state(s): BE CH DE FR GB LI NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19870120

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19870331

RIN1 Information on inventor provided before grant (corrected)

Inventor name: STRELKAUSKAS, ANTHONY J.